ABSTRACT
PENDAHULUAN
Tuberculosis (TB) is still being a significant burden in Indonesia. Among countries in the world, Indonesia is in the third rank of country with TB problem after India (30%) and China (15%). The incidence of TB in Indonesia was 530.000 cases, the prevalence reached 600.000 with 101.000 of mortalities in 2004. According to the national health survey, the completeness of health facilities is still being problem in the east part of Indonesia, thus, there will be unreported TB cases (Awusi et al, 2009 ).
Even the oral antituberculosis (OAT) are affordable in Indonesia, there are other problem related with TB, such as high mortality rate, patients' compliance and adverse drug event. In the 1993, WHO decided that TB is in the emergency situation in the world. It is estimated that there are 7-8 million TB cases and 1.3-1.6 million mortalities every year. In 2010, there were 8.5-9.2 million TB cases and 1.2-1.5 million mortalities of TB and HIV every year (WHO, 2011) . The patients' compliance is one of the key for the successful of treatment for TB, besides nutritional status, host immunity, self and environtment hygiene (Muchid, 2005) .
OAT must be administered regularly for at least 6 months, with 2 months of intensive phase and 4 months of continuation phase. Failure of TB treatment usually caused by incompliance because of the unaffordable drugs. Thus, we need the critical role of pharmacist in managing of TB drug supply and in monitoring patients' compliance (Muchid, 2005) . Drug information service delivered by health proffesionals could increase patients' compliance. The limited human resources in public health centers could be a problem in delivering the drug information service. Patients' compliance is defined as patients' behaviour in using the medicines, following the diet program and changing their life styles (Mahiwa, 2011; Melanie, 2009 ). Patient's uncompliance involves personal believe in drug effectivity, progress of diseases, psychologic factor and social factor (Muchid, 2005) . Tuberculosis can give significant impact to the patients' quality of life. Since this is long duration of treatment, it can cause adverse drug event and may limited patients' daily activities (Guo et al, 2009; Perwitasari et al, 2010) . This study is aimed to understand the impact of drug information service delivered by pharmacist to patients' compliance and quality of life.
METHODS
We used cohort design (cohort event monitoring) with one group patients were delivered by limited OAT information and the other group without OAT information. The limited OAT information which only involved the drug administration were delivered by the pharmacist in two public health centers in Yogyakarta. This service was given to the patients when they take the prescription. We defined the patients' compliance by counting the rest of OAT in the last day of treatment. The patients' quality of life was measured by Indonesian version of Short Formulary -36 (SF-36) questionnaire. The SF-36 questionnaire contains of general health function, physical function, role problem related with the physical function, social function, emotional function, pain, mental function and vitality. The patients' uncompliance risk factors were collected by interview method.
We recruited the TB patients in two public health centers in Yogyakarta for 3 months. These patients with age = 15 were following the TB treatment in the public health centers at least for one month.
Data was analyzed using Chi square test to understand the correlation between some factors and patients' compliance and correlation between drug information service and patients' compliance. The Independent t-test was carried out to understand the impact of OAT information service and patients' quality of life.
RESULTS AND DISCUSSION
We recruited 14 TB patients during 3 months in two public health centers in Yogyakarta. The patients' characteristic are listed in Tabel I.
All of the patients received Fixed Dose Combination (FDC) of OAT. Ten patients (71.4%) were in 20-50 yo, 4 patients were female (42,9%) and 13 patients passed the high school education (92,9%). Only 2 patients experienced tuberculosis for more than 3 months. It means these two patients have been gotten used with the OAT longer than the other group.
The chi square analysis showed that the patient characteristics did not have significant influence to the patients' compliance (P>0.05). This could be caused by limited sample size in this study. However, the drug information service can increase patients' compliance as much as 1.2 times. According to this result, we suggested to the pharmacists in the public health centers, that they should more give awareness in delivering OAT information, not only about how to administer the OAT correctly, but also about the adverse effect, monitoring of adverse effect and how to overcome the adverse effect. These informations will be usefull in increasing patients' compliance and the outcome of treatment will support the succesfull of TB treatment. According to the patients' interview, most of the patients suggested that the drug information service should be delivered by the pharmacist only one time during the treatment duration. This suggestion could be caused by the way of pharmacists in delivering the OAT information is not appropriate or the limited information about OAT. Not only about OAT administration, but also the patients need more information about OAT. Furthermore, TB patients need more discussion in private room and more time to understand about the OAT delivery. The may be ashamed because of their disease, if the information is deliveried in common place. Table II showed the differences of patients' quality of life domains between the group of patients with limited OAT information service and patients without limited OAT information service. It shows that the service of limited OAT information did not give significant impact to the patients' quality of life (p>0.05). This phenomena could be caused by most of te patients were new in TB treatment (less than 3 months). Thus, we still don't know about the impact of TB or Tb treatment in longer duration of treatment. 
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